Daunomycin as an inhibitor of human lens epithelial cell proliferation in culture
- 1 May 1994
- journal article
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 20 (3), 287-290
- https://doi.org/10.1016/s0886-3350(13)80579-2
Abstract
Posterior capsule opacification is still a major complication of both extracapsular cataract extraction and phacoemulsification. We evaluated the effects of the antiproliferative agent daunomycin on cultured human and bovine lens epithelial cell viability and proliferation. After ten minutes of exposure, low concentrations of the agent markedly inhibited the proliferation of both cell types. The calculated LD50 for the drug against human cells was 2.20 μg/ml and against the bovine cells was 0.38 μg/ml. The bovine cells appeared to be slightly more susceptible to the drug’s effects, although this difference was not marked. Our results indicate that daunomycin is a potent inhibitor of both human and bovine lens epithelial cells in the laboratory.Keywords
This publication has 10 references indexed in Scilit:
- Posterior Capsule Polishing and Postoperative Opacification in Intercapsular Cataract SurgeryEuropean journal of Implant and Refractive Surgery, 1992
- Polishing the posterior capsule after extracapsular extraction of senile cataractJournal of Cataract & Refractive Surgery, 1992
- Capsular opacification associated with silicone implantsJournal of Cataract & Refractive Surgery, 1989
- Effect of a plano-convex posterior chamber lens on capsular opacification from Elschnig pearl formationJournal of Cataract & Refractive Surgery, 1988
- Evaluation of daunomycin toxicity on lens epithelium in vitroInternational Ophthalmology, 1988
- Intraocular Daunorubicin for the Treatment and Prophylaxis of Traumatic Proliferative VitreoretinopathyAmerican Journal of Ophthalmology, 1987
- Incidence of posterior capsule opacification in eyes with and without posterior chamber intraocular lensesJournal of Cataract & Refractive Surgery, 1986
- Lens epithelial inhibition by PMMA optic: Implications for lens designJournal of Cataract & Refractive Surgery, 1986
- ANTIPROLIFERATIVE DRUGS IN THE TREATMENT OF EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHYRetina, 1983
- Management of the posterior capsule following posterior chamber lens implantationAmerican Intra-Ocular Implant Society Journal, 1980